Ed Sanguine

Ed Seguine currently serves as the Chief Executive Officer of Elemental Machines since July 2023. Prior to this, Ed held the position of CEO at Clinical Ink from July 2009 to February 2023, where Clinical Ink developed the first Electronic Source Record for clinical trials. Ed has also founded Gordian Technology, LLC, providing consultancy for technology application in the pharmaceutical and healthcare sectors. Previous roles include General Manager at Medidata Solutions, CEO of Fast Track Systems, and various finance positions at Eli Lilly, where significant contributions were made to healthcare IT investments. Ed holds a Bachelor's degree in Management - Finance from Brigham Young University, an MBA in Finance/Decision Strategy from Indiana University, and an Executive Certificate in Strategy and Innovation from MIT Sloan School of Management.